BUSINESS
Exclusive: As polio threat looms, Indonesia's Bio Farma denies contamination of oral vaccine
Bio Farma has come under the lens of Indian drug regulator CDSCO as it supplied bulk vaccine or key starting material to Biomed.
BUSINESS
Will Dr Reddy's biosimilar programme for developed markets see traction?
The drug maker's partner Fresenius Kabi has completed clinical trial for Pegfilgrastim and announced that the drug has met primary end point in two pivotal clinical studies.
BUSINESS
Bio-Med polio episode underlines the story of India's famed vaccine industry losing prowess
India, once the manufacturing powerhouse of vaccines, is seeing a slow decline. India’s vaccines exports dropped 4 percent to $653.40 million in FY18
BUSINESS
Sacked IL&FS MD blames LIC, macro factors for mess, denies fund diversion charges
Sankaran asked NCLT to appoint an independent foreign agency without conflict of interest, rather than a local one, to investigate the company's affairs
BUSINESS
Piramal considers $1-billion pharma services business sale: Reports
But analysts say pharma services constitute 6-7 percent of Piramal's revenues and is a drag on overall pharma business.
BUSINESS
E-pharmacy definition outdated, changes should be made to attract FDI, says IAMAI
The Union Health Ministry recently released draft rules for e-pharmacies to regulate online sale of medicines across the country and provide patients accessibility to genuine drugs.
BUSINESS
Dr Reddy's on cost cutting spree to counter US pricing pressures
The company has been selling manufacturing plants, optimizing product portfolios, removing layers of management that it considers wasteful and taking re-look at R&D investments.
BUSINESS
Biocon-Mylan may benefit from Merck's exit of insulin glargine in US
Insulin glargine is a biosimilar of French drug maker Sanofi's top selling Lantus that had sales of around $5.3 billion in 2017, of which US constitutes around 55 percent.
BUSINESS
Why India needs a comprehensive policy on OTC drugs
Many would be surprised that the term OTC doesn't exist as per Indian law. Neither the Drugs & Cosmetics Act, 1940 nor the Drugs & Cosmetics Rules, 1945 define OTC
BUSINESS
Natco's partner Mylan prevails over Teva in Copaxone patent litigation
Natco's partner Mylan went ahead and launched Copaxone 40 mg “at-risk” in US in October last year even as the patent litigation is still on. Any setbacks in the patent litigation could have led to significant damages among other remedies for both the companies.
BUSINESS
USFDA releases guidance to help generic drug makers copy complex ones
"These draft guidances are aimed at ensuring that we provide as much scientific and regulatory clarity as possible with respect to complex generic drugs," US FDA Commissioner Scott Gottlieb in a statement.
BUSINESS
UP govt woos pharma cos, private healthcare firms with mega parks, public private partnership model
The state has received an investment commitment of about Rs 5,000-6,000 crore from domestic and multinational pharma companies,
BUSINESS
Indian pharma market grows 9.7% in Q2FY19 on uptake across therapy segments
IPM grew close to 10 percent in first half of this financial year FY19, returning to the 10 percent growth of FY17.
BUSINESS
LifeCell rejigs biz after Centre restricts commercial stem cell banking
LifeCell had moved from a private stem cell bank to a community bank unlike a private bank that is exclusively meant for the use of the baby or its immediate family members
BUSINESS
How Indian stent maker SMT is taking the battle to MNC shores
The study called 'Talent trial' was one of the largest ever clinical train conducted by an Indian company overseas to test a medical device
BUSINESS
Gujarat pharma industry says business as usual, but seeks govt action against attacks on migrant workers
Gujarat is the manufacturing hub for pharmaceuticals, housing over 3,300 manufacturing units, including some of the large drug makers such as Sun Pharma, Torrent Pharmaceuticals, Cadila Healthcare and Intas, contributing around 28 percent of India's pharmaceutical exports.
BUSINESS
Why India can't drop the ball on polio-free status
Polio eradication is one of very few success stories that India can boast off, after small pox elimination.
BUSINESS
How Medikabazaar is trying to replicate Amazon model for hospital medical supplies
Medikabazaar has 15,000 active registered users that includes hospitals, clinics, diagnostic centres and individual doctors
BUSINESS
India may face medicine shortage after China cracks down on factories to check pollution
Media reports estimate 40 percent of all China factories have been shut down at some point in the last one year in order to be inspected by environmental bureau officials, resulting in missed orders and increased costs
BUSINESS
Torrent Pharma says charges of duping C&F agents baseless
The company spokesperson said that Torrent Pharma is not liable to pay outstanding dues to C&F agents before June 29, 2014 as per the business transfer agreement .
BUSINESS
US drug regulator issues guidance to tackle delays & speed-up generic approvals
In the latest draft guidance, USFDA tried to tackle a major loophole called 'citizen petitions' used by branded drug makers or innovators to delay the entry of generic drugs
BUSINESS
Holland's Wolter Kluwer bets on Indian healthcare to drive sales
The company gets about 70-80 percent of sales in India from healthcare.
BUSINESS
Dr Reddy's sells US penicillin plant to Abu Dhabi-based Neopharma
The sale of the plant is a part of the company's efforts to rein in costs as it faces intense pricing pressure in the US market, among other disadvantages
BUSINESS
Glenmark banks on complex and differentiated products to beat US pricing pressure
"Pricing pressure (in US) continues. I don't think we are going to see any moderation," Glenn Saldanha, Chairman and Managing Director of Glenmark, told Moneycontrol.
